Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Retained Earnings (2018 - 2025)

Dna X's Retained Earnings history spans 8 years, with the latest figure at -$304.3 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$304.3 million for Q4 2025, down 7.28% from a year ago — trailing twelve months through Dec 2025 was -$304.3 million (down 7.28% YoY), and the annual figure for FY2025 was -$304.3 million, down 7.28%.
  • Retained Earnings for Q4 2025 was -$304.3 million at Dna X, down from -$295.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$205.5 million in Q1 2021 to a low of -$304.3 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$249.8 million (2022), against an average of -$254.7 million.
  • The sharpest move saw Retained Earnings fell 19.69% in 2021, then grew 0.09% in 2023.
  • Year by year, Retained Earnings stood at -$234.8 million in 2021, then dropped by 6.42% to -$249.9 million in 2022, then decreased by 0.04% to -$250.0 million in 2023, then decreased by 13.46% to -$283.6 million in 2024, then dropped by 7.28% to -$304.3 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$304.3 million, -$295.4 million, and -$290.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.